Greenwich Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Greenwich Wealth Management's NVS Position: Q2 2026 in Review
Greenwich Wealth Management held its Novartis (NVS) position steady in Q2 2026 at 11,294 shares worth $1.77M. The position accounts for 0.06% of the portfolio, ranked #122.
Greenwich Wealth Management first reported a position in NVS in Q1 2020 and has held it in 26 quarters since. 1,624 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Greenwich Wealth Management held 11,294 shares of Novartis worth $1.77M as of Q2 2026.
- Greenwich Wealth Management left its Novartis share count unchanged in Q2 2026.
- Novartis made up 0.06% of Greenwich Wealth Management's portfolio in Q2 2026, its #122 holding.
- Greenwich Wealth Management first reported a position in Novartis in Q1 2020 and has held it in 26 quarters since.
- 1,624 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Greenwich Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.